首页> 外文期刊>Journal of immunology research. >Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A
【24h】

Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A

机译:miR-362的异常表达通过下调Sema3A促进肺癌转移

获取原文
       

摘要

miR-362 is a recently discovered member of the microRNA family, and it modulates a variety of physical activities and plays an important role in the occurrence and development of many tumors. However, the biological functions of hsa-miR-362-5p in non-small-cell lung carcinoma (NSCLC) are unknown. Transwell assay and colony formation were used to determine the migration, invasion, and proliferation of NSCLC cells in vitro. A subcutaneous tumor model in nude mice was established to detect NSCLC tumor growth in vivo. The direct binding of miR-362 to the 3UTR of Semaphorin 3A (Sema3A) was confirmed by luciferase reporter assay. In this study, we found that the level of miR-362 was higher in NSCLC tissues than in adjacent normal tissues and that the level of miR-362 expression was also elevated in five NSCLC cell lines (A549, 95-D, H1299, H292, and H460) relative to a human normal lung epithelial cell line (BEAS2B). Furthermore, miR-362 promoted NSCLC cell invasion, migration, and colony formation in vitro and tumor formation in vivo. Next, we identified the miR-362 target gene Sema3A, which is significantly correlated with metastasis. Sema3A expression was increased in normal tissues relative to NSCLC tissues. This result is consistent with the fact that miR-362 expression is negatively correlated with Sema3A expression in clinical tissue samples and indicated that miR-362 can regulate Sema3A expression in NSCLC cells and consequently affect NSCLC invasion, migration, and colony formation. Taken together, these findings on the newly identified miR-362/Sema3A axis elucidate the molecular mechanism of NSCLC invasion and migration and could lead to a potential therapeutic target in NSCLC treatment.
机译:miR-362是最近发现的microRNA家族成员,它调节多种体育活动,并在许多肿瘤的发生和发展中起重要作用。但是,hsa-miR-362-5p在非小细胞肺癌(NSCLC)中的生物学功能尚不清楚。用Transwell测定法和集落形成法测定NSCLC细胞在体外的迁移,侵袭和增殖。建立裸鼠的皮下肿瘤模型以检测体内NSCLC肿瘤的生长。通过荧光素酶报告基因测定证实了miR-362与信号蛋白3A(Sema3A)的3UTR的直接结合。在这项研究中,我们发现NSCLC组织中的miR-362水平高于邻近的正常组织,并且在5种NSCLC细胞系(A549、95-D,H1299,H292中,miR-362的表达水平也升高了) (和H460)相对于人类正常肺上皮细胞系(BEAS2B)。此外,miR-362在体外和体内可促进NSCLC细胞的侵袭,迁移和集落形成。接下来,我们鉴定了与转移密切相关的miR-362目标基因Sema3A。相对于NSCLC组织,Sema3A表达在正常组织中增加。该结果与以下事实一致:miR-362表达与临床组织样本中的Sema3A表达负相关,并表明miR-362可以调节NSCLC细胞中Sema3A的表达,从而影响NSCLC的侵袭,迁移和集落形成。综上所述,在新发现的miR-362 / Sema3A轴上的这些发现阐明了NSCLC入侵和迁移的分子机制,并可能导致NSCLC治疗的潜在治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号